Markets.com Logo

MBLU

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    22.9769$
  • Previous Close
    22.9769$
  • 52 Week Change
    8.29$
  • Day Range
    0.00$
  • 52 Week High/Low
    16.5625$ - 24.8498$
  • Dividend Per Share
    0.0252
  • Market cap
    245 M$
  • EPS
    2.94
  • Beta
    0.184
  • Volume
    --

About

MBLU.US is the stock ticker symbol for Mania Capital Partners Inc. on the US stock market. Mania Capital Partners Inc. is a company focused on acquiring and operating small to medium-sized businesses, primarily within the consumer and industrial sectors. The "US" at the end of the ticker symbol denotes that the stock is traded on a United States exchange.

Trump's Papal Challenge: A Clash Over Moral Authority and Political Influence

Noah Lee|--

Global Markets Show Resilience Amidst Iran Conflict, But Underlying Risks Persist

Emma Rose|--

Iran War Threatens US Labor Market's 'Wonderful Balance': A Deep Dive

Emma Rose|--

Iran's Hormuz Toll Strategy: Post-War Economic Leverage and Geopolitical Realignment

Sophia Claire|--

US Labor Market Outlook: Balancing Recovery Against Escalating Geopolitical Risks

Sophia Claire|--

Global Debt Crisis Deepens Amidst Iran Conflict and Fiscal Fragility

Ava Grace|--

Apple's Strategic Pivot: MacBook Neo, Supply Chain Tactics, and Foldable Phone Hurdles

Emma Rose|--

Factors

Market Sentiment: Overall investor optimism or pessimism towards biotechnology and healthcare sectors impacts MBLU's price.

Clinical Trial Results: Positive or negative data from MBLU's clinical trials for its drug candidates heavily influences investor confidence.

Regulatory Approvals: FDA or other regulatory body approvals of MBLU's products or therapies are significant price catalysts.

Competition: Actions by competitors in the same therapeutic areas can affect MBLU's market potential and valuation.

Financial Performance: MBLU's revenue, expenses, and cash flow influence investor perception of its long-term viability.

Partnerships and Collaborations: Deals with larger pharmaceutical companies or research institutions can boost MBLU's credibility.

Economic Conditions: Broader economic factors like interest rates and inflation can indirectly affect investor risk appetite.

Management Changes: Changes in MBLU's leadership team can lead to uncertainty or optimism depending on the appointments.

Analyst Ratings: Recommendations from financial analysts can influence investor buying or selling decisions.

News and Media Coverage: Positive or negative news stories about MBLU can quickly impact its stock price.

Technological Advancements: Breakthroughs in related technologies may benefit or hinder MBLU's research and development efforts.

Patent Protection: The strength and duration of MBLU's patents affect its ability to maintain market exclusivity.

Financing Activities: Raising capital through stock offerings can dilute existing shareholders and impact the price.

Mergers and Acquisitions: Rumors or actual M&A activity involving MBLU can cause significant price fluctuations.

People Also Watch

Latest news

Close Coordination Between Israel and US on Iran Nuclear Talks Highlighted

Noah Lee|--

US-Iran Talks Show Progress Towards Ceasefire Framework Agreement

Liam James|--

Federal Reserve Independence Under Historic Test: Navigating Democratic Legitimacy and Political Pressure

Liam James|--

Latest Education Articles

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Julian Parker|--
Crypto Trends in 2026: 7 Key Developments Every Investor Should Watch

Crypto Trends in 2026: 7 Key Developments Every Investor Should Watch

Julian Parker|--
Beginners Guide to Fundamental Analysis: What Are the 5 Key Principles of Fundamental Analysis?

Beginners Guide to Fundamental Analysis: What Are the 5 Key Principles of Fundamental Analysis?

Frances Wang|--
Recommended Topics